Remicade (infliximab) is now the first biologic approved for ulcerative colitis

Remicade (infliximab) is now the first biologic approved for ulcerative colitis in Canada.

It's for moderate to severe ulcerative colitis in patients who haven't responded to conventional therapy...5-ASA, steroids, etc.

Remicade can induce remission...prevent colectomy...and reduce or eliminate steroid use.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote